1. Home
  2. ATAI vs SGC Comparison

ATAI vs SGC Comparison

Compare ATAI & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • SGC
  • Stock Information
  • Founded
  • ATAI 2018
  • SGC 1920
  • Country
  • ATAI Germany
  • SGC United States
  • Employees
  • ATAI N/A
  • SGC N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • SGC Apparel
  • Sector
  • ATAI Health Care
  • SGC Consumer Discretionary
  • Exchange
  • ATAI Nasdaq
  • SGC Nasdaq
  • Market Cap
  • ATAI 444.7M
  • SGC 155.7M
  • IPO Year
  • ATAI 2021
  • SGC N/A
  • Fundamental
  • Price
  • ATAI $2.65
  • SGC $10.68
  • Analyst Decision
  • ATAI Strong Buy
  • SGC Strong Buy
  • Analyst Count
  • ATAI 2
  • SGC 3
  • Target Price
  • ATAI $11.00
  • SGC $17.00
  • AVG Volume (30 Days)
  • ATAI 6.0M
  • SGC 51.9K
  • Earning Date
  • ATAI 08-12-2025
  • SGC 08-05-2025
  • Dividend Yield
  • ATAI N/A
  • SGC 5.19%
  • EPS Growth
  • ATAI N/A
  • SGC N/A
  • EPS
  • ATAI N/A
  • SGC 0.45
  • Revenue
  • ATAI $1,863,000.00
  • SGC $563,931,000.00
  • Revenue This Year
  • ATAI $554.22
  • SGC N/A
  • Revenue Next Year
  • ATAI N/A
  • SGC $4.31
  • P/E Ratio
  • ATAI N/A
  • SGC $24.02
  • Revenue Growth
  • ATAI 572.56
  • SGC 2.28
  • 52 Week Low
  • ATAI $1.03
  • SGC $9.11
  • 52 Week High
  • ATAI $2.99
  • SGC $20.75
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 58.75
  • SGC 53.16
  • Support Level
  • ATAI $2.53
  • SGC $10.77
  • Resistance Level
  • ATAI $2.79
  • SGC $11.26
  • Average True Range (ATR)
  • ATAI 0.21
  • SGC 0.36
  • MACD
  • ATAI 0.00
  • SGC 0.02
  • Stochastic Oscillator
  • ATAI 64.55
  • SGC 53.49

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.

Share on Social Networks: